Virus-like particles induce robust human T-helper cell responses.

Virus-like particles induce robust human T-helper cell responses.

Among synthetic vaccines, virus-like particles (VLPs) are used for their ability to induce strong humoral responses. Very little is reported on VLP-based-vaccine-induced CD4(+) T-cell responses, despite the requirement of helper T cells for antibody isotype switching. Further knowledge on helper T...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Braun, M, Jandus, C, Maurer, P, Hammann-Haenni, A, Schwarz, K, Bachmann, M, Speiser, D, Romero, P
Natura:	Journal article
Lingua:	English
Pubblicazione:	2012

Documenti analoghi

Efficient homologous prime-boost strategies for T cell vaccination based on virus-like particles.
di: Schwarz, K, et al.
Pubblicazione: (2005)

Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses
di: Alam, Mohammad Murshid, et al.
Pubblicazione: (2022)

Nano-particle vaccination combined with TLR-7 and -9 ligands triggers memory and effector CD8⁺ T-cell responses in melanoma patients.
di: Goldinger, S, et al.
Pubblicazione: (2012)

Protection against osteoporosis by active immunization with TRANCE/RANKL displayed on virus-like particles.
di: Spohn, G, et al.
Pubblicazione: (2005)

Virus-like particles as a modular system for novel vaccines.
di: Lechner, F, et al.
Pubblicazione: (2002)

The coming of age of virus-like particle vaccines.
di: Jennings, G, et al.
Pubblicazione: (2008)

Special Issue “Virus-Like Particle Vaccines”
di: Monique Vogel, et al.
Pubblicazione: (2020-08-01)

Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.
di: Jegerlehner, A, et al.
Pubblicazione: (2010)

Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design.
di: Bessa, J, et al.
Pubblicazione: (2008)

The kinetics of a memory B cell response to virus like particles in mice
di: Zabel, F, et al.
Pubblicazione: (2012)

The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference
di: Paul Engeroff, et al.
Pubblicazione: (2019-01-01)

Virus-like particles as carriers for T-cell epitopes: limited inhibition of T-cell priming by carrier-specific antibodies.
di: Ruedl, C, et al.
Pubblicazione: (2005)

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies
di: Anne-Cathrine S. Vogt, et al.
Pubblicazione: (2022-06-01)

Use of virus-like particles for therapeutic vaccination against addiction and other chronic diseases
di: Bachmann, M
Pubblicazione: (2005)

Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection.
di: Kopf, M, et al.
Pubblicazione: (2000)

Long-term human T-helper lines producing specific helper factor reactive to influenza virus.
di: Fischer, A, et al.
Pubblicazione: (1981)

Versatile virus-like particle carrier for epitope based vaccines
di: Tissot, A, et al.
Pubblicazione: (2010)

Bacterially produced recombinant influenza vaccines based on virus-like particles
di: Jegerlehner, A, et al.
Pubblicazione: (2013)

Generation of a virus‐like particles based vaccine against IgE
di: Gharailoo, Z, et al.
Pubblicazione: (2024)

T-helper cell-mediated proliferation and cytokine responses against recombinant Merkel cell polyomavirus-like particles.
di: Arun Kumar, et al.
Pubblicazione: (2011-01-01)

Immunotherapy of type-1 allergies with virus-like particles and CpG-motifs.
di: Klimek, L, et al.
Pubblicazione: (2014)

Heterogeneous antibody repertoire of marginal zone B cells specific for virus-like particles.
di: Gatto, D, et al.
Pubblicazione: (2007)

Interaction of viral capsid-derived virus-like particles (VLPs) with the innate immune system
di: Mohsen, M, et al.
Pubblicazione: (2018)

Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis.
di: Spohn, G, et al.
Pubblicazione: (2008)

Adjusted particle size eliminates the need of linkage of antigen and adjuvants for appropriated T cell responses in virus-like particle-based vaccines.
di: Gomes, A, et al.
Pubblicazione: (2017)

A vaccine for hypertension based on virus-like particles: preclinical efficacy and phase I safety and immunogenicity.
di: Ambühl, P, et al.
Pubblicazione: (2007)

Virus-like particles (VLP) in prophylaxis and immunotherapy of allergic diseases
di: Klimek, L, et al.
Pubblicazione: (2018)

M2e-displaying virus-like particles with associated RNA promote T helper 1 type adaptive immunity against influenza A.
di: Lorena Itatí Ibañez, et al.
Pubblicazione: (2013-01-01)

Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells.
di: Engeroff, P, et al.
Pubblicazione: (2017)

T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction?
di: Bachmann, M, et al.
Pubblicazione: (1995)

Preclinical Development of a Novel Zika Virus-like Particle Vaccine in Combination with Tetravalent Dengue Virus-like Particle Vaccines
di: Dominik A. Rothen, et al.
Pubblicazione: (2024-09-01)

Transdermal Immunization with Microparticulate RSV-F Virus-like Particles Elicits Robust Immunity
di: Sucheta D’Sa, et al.
Pubblicazione: (2022-04-01)

COMPLEMENTATION OF H-2-LINKED IR GENES - USE OF HELPER FACTOR TO ANALYZE RESPONSES TO GLYPHE
di: Baltz, M, et al.
Pubblicazione: (1978)

Preclinical antihypertensive efficacy and immunogenicity in humans of a vaccine against angiotensin II based on virus-like particles (VLPs)
di: Tissot, A, et al.
Pubblicazione: (2005)

Fewer protective cytotoxic T-cell epitopes than T-helper-cell epitopes on vesicular stomatitis virus.
di: Kündig, T, et al.
Pubblicazione: (1993)

Conditions for inducing T helper cells in vitro.
di: Kontiainen, S, et al.
Pubblicazione: (1975)

Plug-and-Display: decoration of Virus-Like Particles via isopeptide bonds for modular immunization
di: Brune, K, et al.
Pubblicazione: (2016)

Yellow fever virus vaccination: an emblematic model to elucidate robust human immune responses
di: Amandine Bovay, et al.
Pubblicazione: (2021-08-01)

Bacterially produced recombinant influenza vaccines based on virus-like particles.
di: Andrea Jegerlehner, et al.
Pubblicazione: (2013-01-01)

Vernal keratoconjunctivitis in human immunodeficiency virus – The possible role of T-helper 1–T-helper 2 shift
di: Shweta Agarwal, et al.
Pubblicazione: (2018-01-01)